Actuate Therapeutics Inc (NASDAQ:ACTU) shares, rose in value on Thursday, April 16, with the stock price down by -2.79% to the previous day’s close as strong demand from buyers drove the stock to $8.00.
Actively observing the price movement in the last trading, the stock closed the session at $8.23, falling within a range of $7.92 and $8.19. Referring to stock’s 52-week performance, its high was $11.73, and the low was $5.51. On the whole, ACTU has fluctuated by 8.84% over the past month.
With the market capitalization of Actuate Therapeutics Inc currently standing at about $156.24 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-12.
The stock’s technical analysis shows that the price of ACTU currently trading nearly 8.35% and 7.40% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 56.80, while the 7-day volatility ratio is showing 8.13% which for the 30-day chart, stands at 11.28%. Furthermore, Actuate Therapeutics Inc (ACTU)’s average true range (ATR) is 0.70.
Data on historical trading for Actuate Therapeutics Inc (NASDAQ:ACTU) indicates that the trading volumes over the past 10 days have averaged 42810.0 and over the past 3 months, they’ve averaged 33.06K. According to company’s latest data on outstanding shares, there are 19.53 million shares outstanding.
Nearly 69.92% of Actuate Therapeutics Inc’s shares belong to company insiders and institutional investors own 1.14% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 93272.0 shares as on 2025-03-31, resulting in a short ratio of 2.57. According to the data, the short interest in Actuate Therapeutics Inc (ACTU) stood at 156.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 77351.0. The stock has risen by 0.50% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ACTU stock heading into the next quarter.
